BC
ASPN icon

Bridgefront Capital’s Aspen Aerogels ASPN Stock Holding History

Bridgefront Capital’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,427
Closed -$243K – 616
2024
Q4 		$243K Buy
+20,427
New +$348K 0.08% 427
2024
Q3 		– Sell
-9,217
Closed -$220K – 528
2024
Q2 		$220K Buy
+9,217
New +$216K 0.09% 386

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bridgefront Capital's ASPN Position: Q1 2025 in Review

Bridgefront Capital sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 20,427 shares — an estimated $243K sold.

Bridgefront Capital first reported a position in ASPN in Q2 2024 and held it in 2 quarters. The position peaked at $243K in Q4 2024. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • Bridgefront Capital reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • Bridgefront Capital sold 20,427 Aspen Aerogels shares in Q1 2025, an estimated $243K.
  • Bridgefront Capital first reported a position in Aspen Aerogels in Q2 2024 and held it in 2 quarters.
  • Bridgefront Capital's Aspen Aerogels position peaked at $243K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on Bridgefront Capital's 13F filing for Q1 2025, filed 15 May 2025.